Aysan Valinejad Qanati
Biographic Data
| ID | 8254541 |
|---|---|
| NAME | Aysan Valinejad Qanati |
| GIVEN NAMES | Aysan Valinejad |
| FAMILY NAME | Qanati |
| SIGNATURE | QANATI A V |
| AFFILIATIONS | Tehran University of Medical Sciences |
| ORCID | 0009-0003-4969-7080 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Prevalence, Incidence, and Risk of Different Comorbidity Categories in Pediatric Multiple Sclerosis
A systematic quantification of comorbidity prevalence, incidence (where available), and risk, together with POMS-specific characteristics and any reported impact on clinical outcomes, is anticipated to provide a crucial evidence base for guiding screening, refining management strategies, and informing future research directions. Ultimately, these findings may improve clinical outcomes and quality of life for children and adolescents with MS
No prominent works on this page.
Prevalence, Incidence, and Risk of Different Comorbidity Categories in Pediatric Multiple Sclerosis
A systematic quantification of comorbidity prevalence, incidence (where available), and risk, together with POMS-specific characteristics and any reported impact on clinical outcomes, is anticipated to provide a crucial evidence base for guiding screening, refining management strategies, and informing future research directions. Ultimately, these findings may improve clinical outcomes and quality of life for children and adolescents with MS
Comorbidity (1 work) · Incidence (geometry (1 work) · Meta-analysis and systematic reviews (1 work) · Multiple Sclerosis Research Studies (1 work) · Protocol (science (1 work) · Quality (philosophy (1 work) · Quality of life (healthcare (1 work) · Systematic review (1 work) · Viral Infections and Immunology Research (1 work)